Skip to content
★ Sign in to follow
RZ

Ron Zwanziger

Alere Inc.AMAG Pharmaceuticals Inc.
Total declarations
15
Companies
2
▲ Purchases (4 ops.)
€1.4M
▼ Sales (0 ops.)
—

Latest filing published 05 Nov 2013 for ALERE INC., €122k.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ron Zwanziger: trading record in brief

Filings by Ron Zwanziger span 2 companies, the busiest being Alere Inc. and AMAG Pharmaceuticals Inc. Between 19 December 2006 and 1 November 2013, the trades on record add up to 15 filings.

No open-market sale appears; the market trades are 4 purchases worth €1.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 7 option exercises.

In size, the median ticket on the buying side is €363k.

On 5 November 2013 came the latest disclosure, an option exercise for €122k in Alere Inc. The clock since the last published purchase (24 November 2008) now reads 6,559 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ron Zwanziger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    165,005 USD0SEC
    7,576 shares@ US$21.78Common StockSEC:0001179110-13-016226:0
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    78,761 USD0SEC
    5,065 shares@ US$15.55Common StockSEC:0001179110-12-010420:0
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    1M USD0SEC
    65,000 shares@ US$17.15Common StockSEC:0001179110-11-015547:0
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    124,568 USD0SEC
    9,200 shares@ US$13.54Common StockSEC:0001179110-11-015547:1
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    500,003 USD0SEC
    27,594 shares@ US$18.12Common StockSEC:0001179110-11-015547:2
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    447,600 USD0SEC
    30,000 shares@ US$14.92Common StockSEC:0001179110-11-002385:0
  • ◇
    Chairman, CEO & PresidentExecutivesAlere Inc.
    696,150 USD0SEC
    17,500 shares@ US$39.78Common StockSEC:0001179110-11-002385:1
  • ▲
    Chairman, CEO & PresidentExecutivesAlere Inc.
    104,440 USD0SEC
    7,000 shares@ US$14.92Common StockSEC:0001179110-08-019978:0
    Canonical exit: 22 Feb 2009 (T+90)
  • ▲
    Chairman, CEO & PresidentExecutivesAlere Inc.
    863,580 USD0SEC
    55,500 shares@ US$15.56Common StockSEC:0001179110-08-019978:1
    Canonical exit: 22 Feb 2009 (T+90)
  • ▲
    Chairman, CEO & PresidentExecutivesAlere Inc.
    24,120 USD0SEC
    1,500 shares@ US$16.08Common StockSEC:0001179110-08-019978:2
    Canonical exit: 22 Feb 2009 (T+90)
  • ●
    Chairman, CEO & PresidentExecutivesAlere Inc.
    0SEC
    1,000,000 sharesLoan Interest - Senior Secured Credit FacilitySEC:0001179110-08-019978:3
  • ●
    Chairman, CEO & PresidentExecutivesAlere Inc.
    0SEC
    1,000,000 sharesLoan Interest - Junior Secured Credit FacilitySEC:0001179110-08-019978:4
  • ◆
    DirectorExecutivesAMAG Pharmaceuticals Inc.
    97,375 USD0SEC
    2,500 shares@ US$38.95Common StockSEC:0001104659-08-039069:0
  • ▲
    Chairman, CEO & PresidentExecutivesAlere Inc.
    998,016 USD0SEC
    27,600 shares@ US$36.16Common StockSEC:0001179110-08-011151:0
    Canonical exit: 31 Aug 2008 (T+90)
  • ◆
    Chairman, CEO & PresidentExecutivesAlere Inc.
    4M USD0SEC
    213,321 shares@ US$17.15Common StockSEC:0001179110-07-001793:0

15 of 15 declarations